[Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine].
Martínez Martín
F J
FJ
Servicio de Endocrinología y Nutrición, Hospital General de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria. dr.j.martinez@gmail.com
D000419:Albuminuria / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004095:Dihydropyridines / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007249:Inflammation / Q000188:drug therapy; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000150:complications*; D009578:Nitrobenzenes; D010084:Oxidation-Reduction / Q000187:drug effects; D010879:Piperazines; D013927:Thrombosis / Q000188:drug therapy
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D009578:Nitrobenzenes; D010879:Piperazines; C054218:manidipine